Machine signal
Active cluster buy — 4 distinct insiders, $210.9K, window ends Aug 18, 2026.
Figures computed from official regulatory filings — .
Analysttarget 13.83 USD (+221%) · consensus 4.71/5 · 6 buy · 1 hold · 0 sell
Ownershipinsiders 49% · institutions 27.14% · short 2.3% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Verrica Pharmaceuticals Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH (VP-102) a drug-device combination that contains a GMP-controlled formulation of cantharidin for the treatment of molluscum in adult and pediatric patients, as well as for the treatment of common warts. It also develops VP-315, an oncolytic peptide-based injectable therapy that is in phase II clinical trial for the treatment of dermatology oncologic conditions, which include basal cell carcinoma and other dermatological oncology indications. The company has a collaboration and license agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum and common warts in Japan; and a license agreement with Lytix Biopharma AS to develop and commercialize VP-315 for use in malignant and pre-malignant dermatological indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
84 buys218 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Rosenberg Noah L. | Buy | $20.6K | conv 83Cluster |
| SEC |
| Zawitz David | Buy | $29.9K | conv 68Cluster | SEC |
| Rieger Jaysontrack record | Buy | $101.2K | conv 58 | SEC |
| Kirby John J. | Buy | $24.7K | conv 77Cluster | SEC |
| Rieger Jaysontrack record | Buy | $24.6K | conv 61Cluster | SEC |
| Rosenberg Noah L. | Buy | $10K | conv 66Cluster | SEC |
| Rieger Jaysontrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Eichenfield Lawrence | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| PRYGOCKI MARK A SR | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Corcoran Gavin | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Zawitz David | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Nguyen Diem | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Rosenberg Noah L. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Kirby John J. | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Manning Paul Btrack record | Buy | $11.7M | conv 81ClusterUnusual size | SEC |
| Rieger Jaysontrack record | BuyD (derivative) | n/a (No price was disclosed in the filing) | ClusterFirst in 12mo | SEC |
| Rosenberg Noah L. | Buy | $10K | conv 93ClusterFirst in 12mo | SEC |
| Manning Paul Btrack record | BuyD (derivative) | n/a (No price was disclosed in the filing) | Cluster | SEC |
| Manning Paul Btrack record | Buy | $5.8M | conv 62Cluster | SEC |
| Kirby John J. | Buy | $15K | conv 93ClusterFirst in 12mo | SEC |
| Rosenberg Noah L. | BuyD (derivative) | n/a (No price was disclosed in the filing) | ClusterFirst in 12mo | SEC |
| Rieger Jaysontrack record | Buy | $399.9K | conv 98ClusterFirst in 12mo | SEC |
| Zawitz David | Buy | $42.4K | conv 93ClusterFirst in 12mo | SEC |
| Kirby John J. | BuyD (derivative) | n/a (No price was disclosed in the filing) | ClusterFirst in 12mo | SEC |
| Zawitz David | BuyD (derivative) | n/a (No price was disclosed in the filing) | ClusterFirst in 12mo | SEC |